HEMATOLOGIC COMPLICATIONS OF RHEUMATIC DISEASE THERAPIES
- 1 May 1997
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 23 (2) , 425-437
- https://doi.org/10.1016/s0889-857x(05)70338-0
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Cutaneous vasculitis associated with granulocyte colony-stimulating factorJournal of the American Academy of Dermatology, 1994
- Low‐dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. results of a multicenter randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 1993
- Methotrexate and sulfasalazine combination therapy: Is it worth the risk?Arthritis & Rheumatism, 1993
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- Acute nonlymphocytic leukemia following short‐term, intermittent, intravenous cyclophosphamide treatment of lupus nephritisArthritis & Rheumatism, 1988
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Evidence That the Malignant Lymphoma of Sjögren's Syndrome Is a Monoclonal B-Cell NeoplasmNew England Journal of Medicine, 1978
- Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisJournal of Chronic Diseases, 1978